<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医药笔记 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-19T12:20:06+08:00</updated>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>2020年国内大分子新药研发格局</title>
    <updated>2021-01-19T08:58:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/mPJzGHhGLoplDLRF5NI48g</id>
    <link href="https://mp.weixin.qq.com/s/mPJzGHhGLoplDLRF5NI48g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>纽福斯申报眼病基因疗法NR082</title>
    <updated>2021-01-19T08:58:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/eapIVVhHVH6skpRdehOIPw</id>
    <link href="https://mp.weixin.qq.com/s/eapIVVhHVH6skpRdehOIPw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>北京科兴新冠疫苗获巴西批准</title>
    <updated>2021-01-18T11:21:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/B4vegY1Bn8F3TOTDRa1CaQ</id>
    <link href="https://mp.weixin.qq.com/s/B4vegY1Bn8F3TOTDRa1CaQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Blood：默沙东ROR1 ADC药物治疗里氏转化淋巴瘤</title>
    <updated>2021-01-17T20:42:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/aUhuGeiUKtdRvl6WwwbjRg</id>
    <link href="https://mp.weixin.qq.com/s/aUhuGeiUKtdRvl6WwwbjRg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>ABL Bio：B7-H3/4-1BB双抗</title>
    <updated>2021-01-17T20:42:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/ZnEF98O2B03m2R8b34Nrpg</id>
    <link href="https://mp.weixin.qq.com/s/ZnEF98O2B03m2R8b34Nrpg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>DS-8201获FDA批准治疗胃癌</title>
    <updated>2021-01-16T09:13:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-16:/s/xlXlyRivd5jMt3ZgT3IHVA</id>
    <link href="https://mp.weixin.qq.com/s/xlXlyRivd5jMt3ZgT3IHVA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CD38抗体Darzalex获批第二个适应症：轻链淀粉样变性</title>
    <updated>2021-01-16T09:13:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-16:/s/UKjPs1XNQdaLuq1do4ZG4w</id>
    <link href="https://mp.weixin.qq.com/s/UKjPs1XNQdaLuq1do4ZG4w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>友芝友新型双抗平台：四价对称</title>
    <updated>2021-01-15T07:29:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/v8FumQ9XiweEEY1pgmmh8w</id>
    <link href="https://mp.weixin.qq.com/s/v8FumQ9XiweEEY1pgmmh8w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>细胞因子新疗法：BioNtech启动IL-2+IL-7临床试验</title>
    <updated>2021-01-15T07:29:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/mzX383uxcWGsEEegNizzwQ</id>
    <link href="https://mp.weixin.qq.com/s/mzX383uxcWGsEEegNizzwQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>金斯瑞研发PD-1/CD47双抗</title>
    <updated>2021-01-15T07:29:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/Cb0J2391WKo1lSIzzJIT-A</id>
    <link href="https://mp.weixin.qq.com/s/Cb0J2391WKo1lSIzzJIT-A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>复宏汉霖1.1亿美元引进Trop2抗体</title>
    <updated>2021-01-15T07:29:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/dLgkKAtZn2cm7cWkiQCvdw</id>
    <link href="https://mp.weixin.qq.com/s/dLgkKAtZn2cm7cWkiQCvdw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>NEJM：不同种族、癌种KRAS G12C突变分布</title>
    <updated>2021-01-14T12:10:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/c7i2bjgUUX466GZtLlKSWg</id>
    <link href="https://mp.weixin.qq.com/s/c7i2bjgUUX466GZtLlKSWg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>补体新秀：科越医药JPM会议首度亮相</title>
    <updated>2021-01-14T12:10:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/Hn1cg5pYaV8agPp2NYDusA</id>
    <link href="https://mp.weixin.qq.com/s/Hn1cg5pYaV8agPp2NYDusA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>康宁杰瑞PD-L1纳米抗体治疗脓毒症</title>
    <updated>2021-01-14T12:10:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/9vG5--i8wTWsI5ks5B1mNg</id>
    <link href="https://mp.weixin.qq.com/s/9vG5--i8wTWsI5ks5B1mNg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>齐鲁制药申报首个免疫毒素：Vicineum</title>
    <updated>2021-01-13T12:49:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/BtI8WzlhErgMAIHnOJFJ6A</id>
    <link href="https://mp.weixin.qq.com/s/BtI8WzlhErgMAIHnOJFJ6A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>JPM会议掠影</title>
    <updated>2021-01-13T12:49:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/rMgUf4fnO3OeWYhvFh-6kg</id>
    <link href="https://mp.weixin.qq.com/s/rMgUf4fnO3OeWYhvFh-6kg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>22亿美元合作再现Eylea神奇故事：百济神州PD-1抗体授权给诺华</title>
    <updated>2021-01-12T06:18:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/Nn90YIAVS7ZmYFJipLdJZQ</id>
    <link href="https://mp.weixin.qq.com/s/Nn90YIAVS7ZmYFJipLdJZQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>瑞德西韦2020年销售额28亿美元</title>
    <updated>2021-01-12T06:18:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/KAPgCZwaqgx0IKLSZ-wheQ</id>
    <link href="https://mp.weixin.qq.com/s/KAPgCZwaqgx0IKLSZ-wheQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>EQRx完成5亿美元B轮融资，研发管线来自基石药业、豪森药业等</title>
    <updated>2021-01-12T06:18:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/bS1aLj3ZGiChmzLHEP_wMw</id>
    <link href="https://mp.weixin.qq.com/s/bS1aLj3ZGiChmzLHEP_wMw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Donanemab阿尔茨海默二期临床成功，礼来股价上涨12%</title>
    <updated>2021-01-12T06:18:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/evimmMe6U8OS9VzrxZhpcA</id>
    <link href="https://mp.weixin.qq.com/s/evimmMe6U8OS9VzrxZhpcA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>